Your browser doesn't support javascript.
loading
Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.
Alvarez-Mora, Maria Isabel; Blanco-Palmero, Victor Antonio; Quesada-Espinosa, Juan Francisco; Arteche-Lopez, Ana Rosa; Llamas-Velasco, Sara; Palma Milla, Carmen; Lezana Rosales, Jose Miguel; Gomez-Manjon, Irene; Hernandez-Lain, Aurelio; Jimenez Almonacid, Justino; Gil-Fournier, Belén; Ramiro-León, Soraya; González-Sánchez, Marta; Herrero-San Martín, Alejandro Octavio; Pérez-Martínez, David Andrés; Gómez-Tortosa, Estrella; Carro, Eva; Bartolomé, Fernando; Gomez-Rodriguez, Maria Jose; Sanchez-Calvin, María Teresa; Villarejo-Galende, Alberto; Moreno-Garcia, Marta.
Afiliação
  • Alvarez-Mora MI; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Blanco-Palmero VA; Biochemistry and Molecular Genetic Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
  • Quesada-Espinosa JF; Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Arteche-Lopez AR; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
  • Llamas-Velasco S; Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.
  • Palma Milla C; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Lezana Rosales JM; UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Gomez-Manjon I; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Hernandez-Lain A; UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Jimenez Almonacid J; Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Gil-Fournier B; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
  • Ramiro-León S; Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.
  • González-Sánchez M; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Herrero-San Martín AO; UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Pérez-Martínez DA; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Gómez-Tortosa E; UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Carro E; Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Bartolomé F; UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Gomez-Rodriguez MJ; Neuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Sanchez-Calvin MT; Neuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Villarejo-Galende A; Genetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.
  • Moreno-Garcia M; Genetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.
Int J Mol Sci ; 23(8)2022 Apr 11.
Article em En | MEDLINE | ID: mdl-35457051
ABSTRACT
In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer's disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or family history suggestive of autosomal dominant dementia. Data analysis was based on a custom panel that included 46 genes related to AD and dementia. SORL1 variants were present in a high proportion of patients with candidate variants (15%, 3/20). We expand the clinical manifestations associated with the SORL1 gene by reporting detailed clinical and neuroimaging findings of six unrelated patients with AD and SORL1 mutations. We also present for the first time a patient with the homozygous truncating variant c.364C>T (p.R122*) in SORL1, who also had severe cerebral amyloid angiopathy. Furthermore, we report neuropathological findings and immunochemistry assays from one patient with the splicing variant c.4519+5G>A in the SORL1 gene, in which AD was confirmed by neuropathological examination. Our results highlight the heterogeneity of clinical presentation and familial dementia background of SORL1-associated AD and suggest that SORL1 might be contributing to AD development as a risk factor gene rather than as a major autosomal dominant gene.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article